Literature DB >> 1680542

Antigenic and immunogenic activity of flagella and fimbriae preparations from uropathogenic Proteus mirabilis.

C Legnani-Fajardo1, P Zunino, G Algorta, H F Laborde.   

Abstract

The antigenic and immunogenic activities of fimbriae and flagella from three uropathogenic strains of Proteus mirabilis were compared. Flagella were obtained by mechanical treatment and fimbriae were isolated from cells by heat shock, ammonium sulfate precipitation, sodium deoxycholate and urea treatment, and gel filtration. Both preparations inoculated to mice demonstrated high antigenicity. Titers up to 1:80,000 were determined by an enzyme-linked immunosorbent assay either against the homologous or heterologous strains. When immunized mice were challenged with homologous or heterologous hematogenous infecting doses, a good cross protection was achieved only when fimbriae were used as antigens. Cross-reactivity found between the three fimbriae antisera, and the presence of common proteins in sodium dodecyl sulfate polyacrylamide gel electrophoresis patterns of fimbriae, should validate the study of these proteins to determine the existence of a shared adhesin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680542     DOI: 10.1139/m91-052

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  9 in total

1.  Proteus mirabilis ambient-temperature fimbriae: cloning and nucleotide sequence of the aft gene cluster.

Authors:  G Massad; J F Fulkerson; D C Watson; H L Mobley
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

Review 2.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

3.  Proteus mirabilis mannose-resistant, Proteus-like fimbriae: MrpG is located at the fimbrial tip and is required for fimbrial assembly.

Authors:  X Li; H Zhao; L Geymonat; F Bahrani; D E Johnson; H L Mobley
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

4.  Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.

Authors:  Xin Li; C Virginia Lockatell; David E Johnson; M Chelsea Lane; John W Warren; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene.

Authors:  F K Bahrani; H L Mobley
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

6.  Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection.

Authors:  Greta R Nielubowicz; Sara N Smith; Harry L T Mobley
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

7.  Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection.

Authors:  F K Bahrani; G Massad; C V Lockatell; D E Johnson; R G Russell; J W Warren; H L Mobley
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression.

Authors:  F K Bahrani; H L Mobley
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

9.  Pseudoalteromonas piratica strain OCN003 is a coral pathogen that causes a switch from chronic to acute Montipora white syndrome in Montipora capitata.

Authors:  Silvia Beurmann; Blake Ushijima; Patrick Videau; Christina Marie Svoboda; Ashley Marie Smith; Orion Silverstar Rivers; Greta Smith Aeby; Sean Michael Callahan
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.